ICON plc (ICLR)

156.26
0.46 0.29
NASDAQ : Health Technology
Prev Close 156.72
Open 156.72
Day Low/High 155.88 / 158.26
52 Wk Low/High 118.10 / 165.13
Volume 56.01K
Avg Volume 234.20K
Exchange NASDAQ
Shares Outstanding 54.08M
Market Cap 8.50B
EPS 6.00
P/E Ratio 26.72
Div & Yield N.A. (N.A)
ICON Announces Peter Gray To Retire As CEO

ICON Announces Peter Gray To Retire As CEO

ICON plc (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that Mr.

ICON Selected As A Preferred Provider For Early Phase Clinical Development By Bristol-Myers Squibb

ICON Selected As A Preferred Provider For Early Phase Clinical Development By Bristol-Myers Squibb

ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has been chosen by ...

ICON Reports Second Quarter 2011 Net New Business Of $310 Million, Revenue Of $233 Million And EPS Of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)

ICON Reports Second Quarter 2011 Net New Business Of $310 Million, Revenue Of $233 Million And EPS Of 21c (NASDAQ:ICLR) (ISIN:IE0005711209)

ICON (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the second...

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON Shareholders Vote In Favour Of All Resolutions At Its Annual General Meeting

ICON plc advises that all resolutions recommended by the Board at the Annual General Meeting of the Company held on 18 July 2011 were duly passed by shareholders.

ICON Acquires Firecrest Clinical

ICON Acquires Firecrest Clinical

ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the acquisition of Firecrest ...

ICON Selected By Pfizer As A Global Strategic Partner For Clinical Research And Development

ICON Selected By Pfizer As A Global Strategic Partner For Clinical Research And Development

ICON plc, (NASDAQ: ICLR; ISIN: IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a strategic partnership with...

ICON Forms Strategic Alliance With Boston Clinical Research Institute

ICON Forms Strategic Alliance With Boston Clinical Research Institute

ICON plc, (NASDAQ: ICLR; ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced a strategic alliance with Boston...

ICON Reports First Quarter 2011 Revenue Up 5% To $229 Million And EPS Of 21c

ICON Reports First Quarter 2011 Revenue Up 5% To $229 Million And EPS Of 21c

ICON (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first...

ICON And ACRONET Sign Alliance Agreement In Japan

ICON And ACRONET Sign Alliance Agreement In Japan

ICON plc, (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and ACRONET Corporation, one of Japan’s ...

ICON Reports Full-Year 2010 Revenue Of $900m And EPS Of $1.44

ICON Reports Full-Year 2010 Revenue Of $900m And EPS Of $1.44

ICON (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the full year...

ICON Acquires Oxford Outcomes

ICON Acquires Oxford Outcomes

ICON plc, (NASDAQ:ICLR)(ISIN:IE0005711209) , a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the expansion of its Late Phase and...

ICON Central Laboratories ‘Stands Out As Service Provider That Is More Often Than Not Exceeding Sponsors’ Expectations’

ICON Central Laboratories ‘Stands Out As Service Provider That Is More Often Than Not Exceeding Sponsors’ Expectations’

ICON Central Laboratories - a division of ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries - today...

ICON And Proteome Sciences Partner For The Delivery Of Comprehensive Biomarker Solutions

ICON And Proteome Sciences Partner For The Delivery Of Comprehensive Biomarker Solutions

ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, and Proteome Sciences (AIM:PRM) a leading ...

ICON Announces Appointment Of Cathrin Petty To Board Of Directors

ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Cathrin Petty as...

Icon Reports Revenues Of $225 Million Up 2% On Prior Year (Nasdaq:ICLR) (ISIN:IE0005711209)

Highlights – Third Quarter 2010 * Net revenue of $225 million, a 2% increase vs.

ICON Appoints Alan Morgan To Role Of Group President, Clinical Research Services

ICON plc (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the appointment of Mr.

ICON Shareholders Pass All Resolutions At Its Annual General Meeting

ICON plc, advises that all resolutions recommended by the Board at the Annual General Meeting of the Shareholders of the Company, held on 19 July 2010, were duly passed by shareholders.

ICON Opens Purpose-Built, Hospital Based Translational Medicine Unit In Manchester

ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the official opening of a ...

ICON And Fountain Medical Development (FMD) Announce Opening Of Laboratory Facility In China

ICON And Fountain Medical Development (FMD) Announce Opening Of Laboratory Facility In China

ICON Central Laboratories - a division of ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries –...

ICON Launches Innovative Safety Application To Trend And Graph Laboratory Values

ICON plc (NASDAQ:ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the launch of the ICOLabs™ Medical Review...

ICON Medical Imaging Enhances Technology Platform To Expedite Oncology Clinical Trials

ICON Medical Imaging, a division of ICON Plc (NASDAQ: ICLR), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced the enhancement of...

ICON Acquires Timaq Medical Imaging Inc

ICON plc, (NASDAQ:ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it has acquired Timaq Medical...

ICON Reports Solid First Quarter, With EPS Up 6% Year On Year

ICON (NASDAQ:ICLR)(ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today reported its financial results for the first quarter...

ICON And Tigermed Sign Alliance Agreement In China

ICON (NASDAQ: ICLR)(ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries and Tigermed Consulting, a leader in the provision of ...

ICON Continues Asia-Pacific Expansion With New Office In Manila, Philippines

ICON plc, (NASDAQ: ICLR) (ISIN:IE0005711209), a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries, today announced that it will expand its footprint...

'Fast Money' Recap: Will Oil Kill the Rally?

'Fast Money' Recap: Will Oil Kill the Rally?

The trading panel debated the impact of lower oil prices on the market.

Resistance Levels Review

The major indices' moving averages are still heading down, so they will likely act as resistance the first time up.

A Safer Way to Play the Drug Sector

A Safer Way to Play the Drug Sector

Contract research organizations aren't without risks of course, but they do offer some protection against the vagaries of the industry.

Thursday's Health Winners & Losers

Thursday's Health Winners & Losers

3SBio, Ligand and Quest tumble on disappointing earnings reports.

Wednesday's Health Winners & Losers

Wednesday's Health Winners & Losers

Abiomed wins FDA approval for its ventricular support device.

TheStreet Quant Rating: A (Buy)